{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-042288","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2024-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.468282+00:00","generated_at":"2026-06-04T01:50:40.308051+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Iterum Therapeutics receives Nasdaq delisting notice for equity deficit of $6.4M","bullets":["Stockholders' equity deficit of $6.4M as of Dec 31, 2023, below Nasdaq's $2.5M minimum.","Company must submit a compliance plan by May 20, 2024; Nasdaq may extend deadline to Sept 30, 2024.","If plan is rejected or compliance not regained, delisting proceedings may begin with appeal rights.","Iterum is evaluating options to resolve the deficiency; listing continues for now."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-042288","json":"https://secwatch.observer/filing/0000950170-24-042288.json","markdown":"https://secwatch.observer/filing/0000950170-24-042288.md","text":"https://secwatch.observer/filing/0000950170-24-042288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024042288/0000950170-24-042288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024042288/itrm-20240403.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:50:40.308051+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4afcafaa94c5559ab34e0a225e4feb1ac9e8dde2","claim":"Iterum Therapeutics plc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"April 3, 2024, Iterum Therapeutics plc (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), because (i) the stockholders’ equity (deficit) of the Company of ($6,403,000) as of December 31, 2023, as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, was below the minimum stockholders’ equity requirement of $2,500,000 and (ii) the Company did not, as of April 3, 2024, meet the alternatives standards of market value of listed securities or net income from c","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024042288/0000950170-24-042288-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}